Lawrence T. Park

2.8k total citations · 2 hit papers
35 papers, 1.9k citations indexed

About

Lawrence T. Park is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Lawrence T. Park has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 18 papers in Biological Psychiatry and 9 papers in Experimental and Cognitive Psychology. Recurrent topics in Lawrence T. Park's work include Treatment of Major Depression (25 papers), Tryptophan and brain disorders (18 papers) and Mental Health Research Topics (7 papers). Lawrence T. Park is often cited by papers focused on Treatment of Major Depression (25 papers), Tryptophan and brain disorders (18 papers) and Mental Health Research Topics (7 papers). Lawrence T. Park collaborates with scholars based in United States, Czechia and Canada. Lawrence T. Park's co-authors include Carlos A. Zarate, Elizabeth D. Ballard, Allison C. Nugent, Ioline D. Henter, Mark J. Niciu, Nancy E. Brutsché, Marc S. Lener, Minkyung Park, Bashkim Kadriu and Ruin Moaddel and has published in prestigious journals such as New England Journal of Medicine, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Lawrence T. Park

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

2016 334 citations Marc S. Lener, Mark J. Niciu et al. Biological Psychiatry profile →
Depression in the Primary Care Setting

2019 281 citations Lawrence T. Park, Carlos A. Zarate New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence T. Park United States	20	894	890	453	342	290	35	1.9k
Sarah Pillemer United States	10	1.3k 1.4×	1.0k 1.2×	420 0.9×	339 1.0×	158 0.5×	13	1.9k
Lee C. Chang United States	13	1.6k 1.8×	1.3k 1.5×	483 1.1×	404 1.2×	213 0.7×	17	2.1k
Yanling Zhou China	24	845 0.9×	790 0.9×	170 0.4×	355 1.0×	215 0.7×	136	1.7k
Kimberly Cooper United States	14	1.2k 1.4×	869 1.0×	388 0.9×	269 0.8×	194 0.7×	25	1.9k
André Tadić Germany	24	646 0.7×	417 0.5×	343 0.8×	474 1.4×	434 1.5×	43	1.9k
Laili Soleimani United States	16	798 0.9×	690 0.8×	315 0.7×	175 0.5×	141 0.5×	35	1.3k
Rayan K. Al Jurdi United States	15	1.1k 1.3×	962 1.1×	348 0.8×	281 0.8×	307 1.1×	21	1.9k
Charles R. Conway United States	25	818 0.9×	385 0.4×	297 0.7×	530 1.5×	188 0.6×	66	2.4k
Stefan Kloiber Germany	26	677 0.8×	834 0.9×	391 0.9×	298 0.9×	426 1.5×	96	2.9k
Masaki Kato Japan	22	815 0.9×	524 0.6×	689 1.5×	285 0.8×	231 0.8×	123	2.5k

Countries citing papers authored by Lawrence T. Park

Since Specialization

Citations

This map shows the geographic impact of Lawrence T. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence T. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence T. Park more than expected).

Fields of papers citing papers by Lawrence T. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence T. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence T. Park. The network helps show where Lawrence T. Park may publish in the future.

Co-authorship network of co-authors of Lawrence T. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence T. Park. A scholar is included among the top collaborators of Lawrence T. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence T. Park. Lawrence T. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnston, Jenessa N., Ioline D. Henter, Christoph Kraus, et al.. (2023). Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile. Drug Discovery Today. 28(4). 103518–103518. 41 indexed citations

Park, Lawrence T., et al.. (2023). Assessing geographic disparities in mental health research participation. Contemporary Clinical Trials. 131. 107244–107244. 3 indexed citations

Medeiros, Gustavo C., Dede Greenstein, Peixiong Yuan, et al.. (2023). κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of Clinical Psychopharmacology. 43(2). 89–96. 2 indexed citations

Yavi, Mani, et al.. (2023). An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 43(5). 422–427. 1 indexed citations

Moaddel, Ruin, Panos Zanos, Cristan Farmer, et al.. (2022). Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration. Translational Psychiatry. 12(1). 179–179. 20 indexed citations

Yavi, Mani, et al.. (2022). Ketamine treatment for depression: a review. Discover Mental Health. 2(1). 9–9. 80 indexed citations

Henter, Ioline D., Lawrence T. Park, & Carlos A. Zarate. (2021). Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status. CNS Drugs. 35(5). 527–543. 101 indexed citations

Ballard, Elizabeth D., Dede Greenstein, Kimberly Swartz, et al.. (2021). The mental health impact of contact with COVID-19 patients on healthcare workers in the United States. Psychiatry Research. 308. 114359–114359. 7 indexed citations

Farmer, Cristan, Jessica R. Gilbert, Ruin Moaddel, et al.. (2020). Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology. 45(8). 1398–1404. 65 indexed citations

10.

Greenstein, Dede, et al.. (2019). Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression. Journal of Affective Disorders. 263. 568–575. 67 indexed citations

11.

Park, Lawrence T. & Carlos A. Zarate. (2019). Depression in the Primary Care Setting. New England Journal of Medicine. 380(6). 559–568. 281 indexed citations breakdown →

12.

Kadriu, Bashkim, Cristan Farmer, Peixiong Yuan, et al.. (2019). The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Molecular Psychiatry. 26(8). 4085–4095. 66 indexed citations

13.

Nugent, Allison C., Elizabeth D. Ballard, Todd D. Gould, et al.. (2018). Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Molecular Psychiatry. 24(7). 1040–1052. 167 indexed citations

14.

Niciu, Mark J., Bridget Shovestul, Cristan Farmer, et al.. (2018). Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. Journal of Affective Disorders. 232. 310–315. 97 indexed citations

15.

Duncan, Wallace C., Elizabeth E. Slonena, Nadia S. Hejazi, et al.. (2018). Are 24-hour motor activity patterns associated with continued rapid response to ketamine?. Neuropsychiatric Disease and Treatment. Volume 14. 2739–2748. 12 indexed citations

16.

Kadriu, Bashkim, Shiwen Yuan, Cristan Farmer, et al.. (2018). Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. Journal of Clinical Psychopharmacology. 38(3). 243–246. 3 indexed citations

17.

Lener, Marc S., Mark J. Niciu, Elizabeth D. Ballard, et al.. (2016). Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biological Psychiatry. 81(10). 886–897. 334 indexed citations breakdown →

18.

Voort, Jennifer L. Vande, Elizabeth D. Ballard, Rebecca A. Bernert, et al.. (2016). Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder. The Journal of Clinical Psychiatry. 78(8). 1068–1074. 53 indexed citations

19.

Park, Lawrence T., Caleb J. Siefert, Grace Chiou, et al.. (2010). Two Routine Blood Tests—Mean Corpuscular Volume and Aspartate Aminotransferase—as Predictors of Delirium Tremens in Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 69(1). 199–201. 12 indexed citations

20.

Park, Lawrence T., et al.. (2008). Case 14-2008. New England Journal of Medicine. 358(19). 2051–2059. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact